Marshall Baughman

Concert is a healthcare technology company enabling cost-effective access to diagnostics and therapeutics by harmonizing evidence, policy, and payment. Founded in 2010 to bring transparency and efficiency to genetic testing, Concert now offers the definitive precision health payment accuracy platform. The Diagnostic Benefit Program, Concert's laboratory management solution for health plans, provides transparent, evidence-based policies, a synchronized library of claim edits, and technical integration capabilities that can deliver this content through the customer’s preferred clinical decision support and claims editing platforms. These capabilities enable plans to improve transparency, reduce administrative burden and achieve cost savings, all while keeping pace with the rapidly evolving market. Health plans, health systems, laboratories, and an extensive network of partner organizations trust Concert to provide the content, technology, and integration capabilities to deliver precision health data integration and payment accuracy directly into the systems of record, ultimately enabling consumers cost-effective access to the latest in precision care. Concert Genetics now operates by its abbreviated name, Concert, which many customers and partners have used for years to refer to the company.